In peptide research, purity is not an abstract virtue. It is the foundation that determines whether experimental results reflect the compound under study or an artifact of contamination. A peptide reported at 99% purity by HPLC is not the same as a peptide of unknown origin sold with vague claims, and in a research setting the difference can invalidate months of work.

What Purity Actually Measures

The standard method for assessing peptide purity is High-Performance Liquid Chromatography, commonly abbreviated HPLC. This analytical technique separates the components of a sample based on their interactions with a stationary phase and a mobile phase, producing a chromatogram where each component appears as a distinct peak.

The percentage associated with purity reflects the area of the target peptide’s peak relative to all detected peaks. A peptide reported at 99% HPLC purity contains no more than 1% of detectable impurities under the analytical conditions used.

Mass Spectrometry Confirmation

HPLC confirms purity; mass spectrometry (MS) confirms identity. By measuring the mass-to-charge ratio of ionized molecules, MS verifies that the peptide in the vial matches the intended amino acid sequence within a fraction of a Dalton.

Research-grade peptides should be supplied with both HPLC and MS data. Together, these techniques answer the two fundamental questions a researcher must ask of any compound: Is this the molecule I ordered? And how pure is it?

The Certificate of Analysis

A Certificate of Analysis, or COA, is the formal document that accompanies a research compound and reports its analytical specifications. A complete COA for a research peptide should include:

• Product name, lot number, and manufacturing date
• HPLC chromatogram with percent purity
• Mass spectrometry data confirming molecular weight
• Amino acid sequence and molecular formula
• Residual solvent analysis where applicable
• Heavy metals testing results
• Storage and handling recommendations

Without a Certificate of Analysis, a research peptide is unverified material. With one, it becomes a documented compound that can be cited, compared, and reproduced.

Heavy Metals and Residual Solvents

Peptide synthesis involves reagents and solvents that must be removed during purification. Residual trifluoroacetic acid (TFA), acetonitrile, or N,N-dimethylformamide can confound biological assays and introduce variables that no researcher wants in their data. Heavy metal contamination, while rare in properly manufactured peptides, is tested against United States Pharmacopeia standards.

Why This Matters for Research

Irreproducibility in biological research has become a widely documented concern. A substantial share of the problem traces back to the quality of reagents and compounds used. A peptide of unknown purity, from an unverified source, introduces uncertainty that no experimental design can correct after the fact.

For Bastet Biosciences, every compound in the catalog is supplied with a full Certificate of Analysis, manufactured to research-grade specifications, and tested at 99% HPLC purity as a minimum standard. This is not a selling point. It is the baseline expectation of anyone who has ever tried to replicate a result.

Further reading

[1] U.S. Pharmacopeia. General Chapter <232> Elemental Impurities—Limits. USP-NF Online.

[2] International Council for Harmonisation. ICH Q3C Impurities: Guideline for Residual Solvents. 2021 revision.

[3] Baker M. 1,500 scientists lift the lid on reproducibility. Nature. 2016;533:452-454. doi:10.1038/533452a